Latest News

Cure SMA Releases Schedule for the 2017 Annual SMA Conference

March 21, 2017
Posted in ,

Cure SMA has released the schedule for the 2017 Annual SMA Conference, to be held at Walt Disney World in Orlando, FL, June 29 – July 2. The schedule includes […]

Read More ›

Cure SMA Awards $140,000 Grant to Joceyln C̫t̩, PhD, University of Ottawa

March 21, 2017
Posted in ,

Cure SMA has awarded a $140,000 research grant to Joceyln Côté, PhD, at The University of Ottawa, for his project, “Investigating the mechanism by which SMN regulates translation: identification of […]

Read More ›

American College of Obstetricians and Gynecologists Recommends Expanded SMA Carrier Screening

March 20, 2017
Posted in ,

The American College of Obstetricians and Gynecologists has released updated guidance on carrier testing for genetic conditions. The updated guidance includes, for the first time, a recommendation that all women […]

Read More ›

AveXis Reports Results from Phase 1 Trial of AVXS-101

March 16, 2017
Posted in ,

AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today reported topline results from the Phase 1 trial of AVXS-101 […]

Read More ›

Know Your Resources: How Congressional Caseworkers Can Help You Obtain Insurance Coverage for New Therapies

March 15, 2017
Posted in , ,

Your elected officials who represent you in Washington, D.C. have caseworkers in their regional and district offices in your communities. These caseworkers can help you work with and better understand […]

Read More ›

Cure SMA Awards $140,000 Grant to Arthur Burghes, PhD, The Ohio State University

March 15, 2017
Posted in , ,

Cure SMA has awarded a $140,000 research grant to Arthur Burghes, PhD, at The Ohio State University, for his project, “Identification of SMA modifiers and deletion/duplication junctions in the SMA […]

Read More ›
Scroll to Top